Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors.

ABSTRACT:

Introduction

Chemotherapy for breast cancer has been associated with cognitive problems; however, the impact of adjuvant hormone therapy is less clear. No studies have explored provider discussions about cognitive concerns or factors associated with neurocognitive treatment. This study examined cognitive problems, factors associated with having a provider discussion, and receipt of neurocognitive treatment.

Methods

Female breast cancer survivors (N=2,537) from the Sister Study and the Two Sister Study who were at least 1 year post-treatment were surveyed in 2012 about their cancer therapies (confirmed by medical records); cognitive concerns; related provider discussions; and neurocognitive treatment. A total of 2,296 women were included in the current 2014 analysis. Extensiv

SUBMITTER: Buchanan ND 

PROVIDER: S-EPMC4656130 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature